Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer
Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 a...
Saved in:
Published in | Tumor biology Vol. 34; no. 1; pp. 329 - 336 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.02.2013
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (
N
= 15) and healthy subjects (
N
= 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61;
p
< 0.01; in H4K20me3: 54 vs. 88;
p
< 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones. |
---|---|
AbstractList | Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (
N
= 15) and healthy subjects (
N
= 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61;
p
< 0.01; in H4K20me3: 54 vs. 88;
p
< 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones. Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N=15) and healthy subjects (N=15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p<0.01; in H4K20me3: 54 vs. 88; p<0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.[PUBLICATION ABSTRACT] Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N=15) and healthy subjects (N=15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p<0.01; in H4K20me3: 54 vs. 88; p<0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones. Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N = 15) and healthy subjects (N = 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p < 0.01; in H4K20me3: 54 vs. 88; p < 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones.Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation (ChIP)-related quantitative PCR, we described reduced plasma levels of the two pericentric heterochromatin-specific histone methylation marks H3K9me3 and H4K20me3 in patients with colorectal cancer (CRC). Here, by utilizing ChIP-related high-throughput sequencing, we further characterized these modifications in circulation. Plasma DNA from nucleosomes immunoprecipitated by H3K9me3- and H4K20me3-specific antibodies from patients with CRC (N = 15) and healthy subjects (N = 15) was subjected to the Roche 454 FLX sequencing, and the generated array of ChIP-enriched sequences were compared to the human reference genome. The total number of nucleosomes, of sequence reads and of diverse DNA repetitive elements were statistically compared between the study groups. Total nucleosome amount was not different in both groups. Concerning both histone modifications, lower numbers of sequence reads were detected in CRC patients as compared with healthy controls (medians in H3K9me3: 32 vs. 61; p < 0.01; in H4K20me3: 54 vs. 88; p < 0.01). Size of fragments was not different in both groups. Most abundant sequences were repetitive LINE and SINE elements while simple repeats, LTR, DNA, SAT, and low complexity elements were less frequent. Best discrimination between both groups was achieved by total number of H3K9me3 reads (AUC 0.90) and H3K9me3 LINE elements L1 (AUC 0.93) und L2 (AUC 0.91). The present results confirm earlier findings of lower H3K9me3 levels in CRC and show LINE elements to be the most frequent and best discriminative markers on modified histones. |
Author | Holdenrieder, Stefan Cakiris, Aris Abaci, Neslihan Leszinski, Gloria Üstek, Duran Dalay, Nejat Gezer, Ugur Yörüker, Ebru E. |
Author_xml | – sequence: 1 givenname: Ugur surname: Gezer fullname: Gezer, Ugur email: ugurd@istanbul.edu.tr organization: Department of Basic Oncology, Istanbul University Oncology Institute, Capa – sequence: 2 givenname: Duran surname: Üstek fullname: Üstek, Duran organization: Institute of Experimental Medicine, Istanbul University – sequence: 3 givenname: Ebru E. surname: Yörüker fullname: Yörüker, Ebru E. organization: Department of Basic Oncology, Istanbul University Oncology Institute, Capa – sequence: 4 givenname: Aris surname: Cakiris fullname: Cakiris, Aris organization: Institute of Experimental Medicine, Istanbul University – sequence: 5 givenname: Neslihan surname: Abaci fullname: Abaci, Neslihan organization: Institute of Experimental Medicine, Istanbul University – sequence: 6 givenname: Gloria surname: Leszinski fullname: Leszinski, Gloria organization: Institute of Clinical Chemistry, University Hospital Munich – sequence: 7 givenname: Nejat surname: Dalay fullname: Dalay, Nejat organization: Department of Basic Oncology, Istanbul University Oncology Institute, Capa – sequence: 8 givenname: Stefan surname: Holdenrieder fullname: Holdenrieder, Stefan email: Stefan.Holdenrieder@uni-bonn.de organization: Institute of Clinical Chemistry, University Hospital Munich, Institute of Clinical Chemistry and Pharmacology, University Hospital Bonn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23086575$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0U-P1CAYBnBi1rh_9AN4MSRevKAvUEp73MyqY3ajFz03DH07ZdPCCPSwXv3iUmc1ZhP1BCS_B17ynJMTHzwS8pzDaw6g3yQuhdYMuGCgVMXUI3LGKyEZyAZOyh44sEo08pScp3QLwFXb1k_IqZDQ1EqrM_J9M5pobMbovpnsgqdhoFt53c4oGTW-p9vqWsB6MikF60zGnloX7TIV7_fUL3bCkMJsJnr18ZLu7ujo9iPLYwzLfjwsmSb8uqC3q3ae2jCFiDYXb423GJ-Sx4OZEj67Xy_Il3dvP2-27ObT-w-byxtmK1CZabuz2KKQpuK6NkLxdpAWYKfa2kDb46CattF1b6qe942VdaGDVKhQ9AJbeUFeHe89xFAGSrmbXbI4TcZjWFLHJVe1EFUN_6dCSw2gQBf68gG9DUv05SOr4k1Trq2KenGvlt2MfXeIbjbxrvvVRAH8CGwMKUUcfhMO3dp2d2y7K213a9vdmtEPMtblny3maNz0z6Q4JlN5xe8x_jH0X0M_AAEbvJY |
CitedBy_id | crossref_primary_10_1098_rsob_200119 crossref_primary_10_3390_cancers9010005 crossref_primary_10_1080_00365521_2017_1299212 crossref_primary_10_3390_diagnostics12040870 crossref_primary_10_1515_medgen_2023_2065 crossref_primary_10_1053_j_gastro_2015_07_011 crossref_primary_10_1016_j_cca_2020_12_008 crossref_primary_10_1016_j_jncc_2022_09_002 crossref_primary_10_1080_15592294_2017_1300729 crossref_primary_10_1111_febs_15707 crossref_primary_10_1038_s41587_020_00775_6 crossref_primary_10_3389_fcell_2021_622459 crossref_primary_10_1016_j_bbrc_2014_08_002 crossref_primary_10_1016_j_lungcan_2020_07_023 crossref_primary_10_1038_s41575_019_0230_y crossref_primary_10_1586_17474124_2014_924397 crossref_primary_10_18632_oncotarget_12751 crossref_primary_10_3390_cancers10040101 crossref_primary_10_1016_j_cancergen_2017_11_001 crossref_primary_10_3390_ijms161226180 crossref_primary_10_5217_ir_2023_00115 crossref_primary_10_38079_igusabder_1105142 crossref_primary_10_1186_1471_2407_14_531 crossref_primary_10_3390_pathogens5010018 crossref_primary_10_4331_wjbc_v6_i4_333 crossref_primary_10_1007_s12253_019_00663_8 crossref_primary_10_1055_s_0042_1757404 crossref_primary_10_1038_s41598_022_19174_9 crossref_primary_10_1515_labmed_2022_0030 crossref_primary_10_25122_jml_2023_0269 crossref_primary_10_1016_j_bbadis_2022_166512 crossref_primary_10_1016_j_it_2023_03_005 crossref_primary_10_3171_2019_6_PEDS19259 crossref_primary_10_3390_diagnostics12092147 crossref_primary_10_3389_fgene_2023_1152470 crossref_primary_10_1016_j_cca_2016_01_016 crossref_primary_10_1053_j_gastro_2022_10_036 crossref_primary_10_1080_1354750X_2016_1252961 crossref_primary_10_1002_advs_202309424 crossref_primary_10_1586_erm_13_37 crossref_primary_10_1053_j_gastro_2020_09_058 |
Cites_doi | 10.1080/10408360802485875 10.1038/nature06008 10.1016/S1097-2765(03)00477-5 10.1016/S1097-2765(03)00479-9 10.1186/1759-8753-1-2 10.1128/MCB.01684-06 10.1016/j.cell.2007.05.009 10.1373/clinchem.2007.101766 10.1158/1078-0432.CCR-08-0869 10.1038/sj.emboj.7600545 10.1016/j.cca.2009.08.011 10.2174/156652410790963295 10.1016/j.tig.2004.08.008 10.1128/MCB.01529-06 10.1373/clinchem.2008.113597 10.1371/journal.pone.0006659 10.1038/ng1531 10.1093/clinchem/48.8.1212 |
ContentType | Journal Article |
Copyright | International Society of Oncology and BioMarkers (ISOBM) 2012 International Society of Oncology and BioMarkers (ISOBM) 2013 |
Copyright_xml | – notice: International Society of Oncology and BioMarkers (ISOBM) 2012 – notice: International Society of Oncology and BioMarkers (ISOBM) 2013 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7TO 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7TM |
DOI | 10.1007/s13277-012-0554-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Research Library Biological Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Nucleic Acids Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic Nucleic Acids Abstracts |
DatabaseTitleList | Publicly Available Content Database Nucleic Acids Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1423-0380 |
EndPage | 336 |
ExternalDocumentID | 2871343391 23086575 10_1007_s13277_012_0554_5 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .GJ 06D 0VX 0VY 0~B 123 1N0 203 29Q 29~ 2KM 2LR 2VQ 30V 30W 328 36B 3V. 4.4 408 40D 53G 67N 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8UI 8UJ 96X AAIAL AAJKR AARHV AARTL AASGM AAWCG AAYIC AAYIU AAYQN AAYTO AAYZH AAZMS ABBTS ABJOX ABPLI ABQXT ABTEG ABTHY ABTMW ABUWG ABWCG ACBXY ACGFS ACKNC ACPQW ACPRK ACQXL ADAGL ADBBV ADHIR ADINQ ADKPE ADZMO AEGNC AEJHL AENEX AEOHA AEPYU AETCA AEWDL AEYAO AFBBN AFCOW AFDXO AFKRA AFKRG AFLOW AFRWT AFSIO AFWTZ AFZKB AGAYW AGJBK AGQMX AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIIXL AIOMO AJBLW AJUZI AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP ANMIH AUTPY AYAKG AZQEC BBNVY BCNDV BDDNI BENPR BGNMA BHPHI BPHCQ BSEHC BVXVI CAG CCPQU COF CS3 CSCUP CYUIP DU5 DV7 DWQXO E0A EBD EBS EJD EMB EMOBN EN4 ESBYG F5P FB. FRRFC FYJPI FYUFA GGRSB GNUQQ GQ6 GQ7 GROUPED_DOAJ GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION GUQSH H13 HCIFZ HF~ HMCUK HMJXF HRMNR HZ~ IOS ITM J0Z J8X JBSCW K.F KOV LK8 M1P M2O M4Y M7P N9A NQS NU0 O1H O9- O93 O9I OK1 PADUT PIMPY PQQKQ PROAC PSQYO Q2X R9I RIG RKO ROL RSV RXVBD S1Z S27 S3A S3B SAUOL SBL SFC SHX SOJ SV3 T13 U2A U9L UDS UG4 UJ6 UKHRP VC2 W48 WK8 Z45 ZOVNA ZXP ~A9 0R~ AAYXX ABFSG ACHEB ACSTC AEZWR AFHIU AHWEU AIXLP CITATION PHGZM PHGZT SCNPE CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7T5 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI PRINS PUEGO Q9U 7X8 7TM |
ID | FETCH-LOGICAL-c405t-7cbce9e23a4176a2519f3c00b596a09def589876da4d1d8c3623af35e5e2d2e93 |
IEDL.DBID | U2A |
ISSN | 1010-4283 1423-0380 |
IngestDate | Fri Jul 11 09:52:17 EDT 2025 Fri Jul 11 03:19:20 EDT 2025 Sat Aug 23 14:57:58 EDT 2025 Mon Jul 21 06:02:14 EDT 2025 Thu Apr 24 22:57:34 EDT 2025 Tue Jul 01 02:37:11 EDT 2025 Fri Feb 21 02:38:42 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Circulating nucleosomes Histone methylation High-throughput nucleotide sequencing Colorectal cancer |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c405t-7cbce9e23a4176a2519f3c00b596a09def589876da4d1d8c3623af35e5e2d2e93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/1271881314?pq-origsite=%requestingapplication% |
PMID | 23086575 |
PQID | 1271881314 |
PQPubID | 33651 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1315622460 proquest_miscellaneous_1273700507 proquest_journals_1271881314 pubmed_primary_23086575 crossref_primary_10_1007_s13277_012_0554_5 crossref_citationtrail_10_1007_s13277_012_0554_5 springer_journals_10_1007_s13277_012_0554_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-02-01 |
PublicationDateYYYYMMDD | 2013-02-01 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: United States – name: London |
PublicationSubtitle | Tumor Markers, Tumor Targeting and Translational Cancer Research |
PublicationTitle | Tumor biology |
PublicationTitleAbbrev | Tumor Biol |
PublicationTitleAlternate | Tumour Biol |
PublicationYear | 2013 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | Fraga, Ballestar, Villar-Garea, Boix-Chornet, Espada, Schotta (CR5) 2005; 37 Kim, Kiefer, Dean (CR17) 2007; 27 Martens, O'Sullivan, Braunschweig, Opravil, Radolf, Steinlein, Jenuwein (CR14) 2005; 24 Deligezer, Akisik, Erten, Dalay (CR4) 2008; 54 Beck, Urnovitz, Riggert, Clerici, Schütz (CR13) 2009; 55 CR19 Rice, Briggs, Ueberheide, Barber, Shabanowitz, Hunt (CR8) 2003; 12 Holdenrieder, Stieber (CR2) 2009; 46 Vakoc, Sachdeva, Wang, Blobel (CR18) 2006; 26 Ng, Tsui, Lam, Chiu, Yu, Wong (CR3) 2002; 48 Nikolaev, Iseli, Sharp, Robyr, Rougemont, Gehrig (CR21) 2009; 4 Leszinski, Gezer, Siegele, Stoetzer, Holdenrieder (CR11) 2012; 32 van der Vaart, Semenov, Kuligina (CR12) 2009; 409 Peters, Kubicek, Mechtler, O'Sullivan, Derijck, Perez-Burgos (CR7) 2003; 12 van den Broeck, Brambilla, Moro-Sibilot, Lantuejoul, Brambilla, Eymin (CR6) 2008; 14 Barski, Cuddapah, Cui, Roh, Schones, Wang (CR9) 2007; 129 Huda, Mariño-Ramírez, Jordan (CR16) 2010; 1 Vlassov, Laktionov, Rykova (CR1) 2010; 10 Deligezer, Akisik, Akisik, Kovancilar, Bugra, Erten, Gahan (CR10) 2011 Mikkelsen, Ku, Jaffe, Issac, Lieberman, Giannoukos (CR15) 2007; 448 Rudd, Willard (CR20) 2004; 20 U Deligezer (554_CR4) 2008; 54 A Broeck van den (554_CR6) 2008; 14 A Huda (554_CR16) 2010; 1 U Deligezer (554_CR10) 2011 VV Vlassov (554_CR1) 2010; 10 MF Fraga (554_CR5) 2005; 37 JC Rice (554_CR8) 2003; 12 A Barski (554_CR9) 2007; 129 S Holdenrieder (554_CR2) 2009; 46 EK Ng (554_CR3) 2002; 48 AH Peters (554_CR7) 2003; 12 JH Martens (554_CR14) 2005; 24 M Vaart van der (554_CR12) 2009; 409 MK Rudd (554_CR20) 2004; 20 A Kim (554_CR17) 2007; 27 G Leszinski (554_CR11) 2012; 32 J Beck (554_CR13) 2009; 55 CR Vakoc (554_CR18) 2006; 26 TS Mikkelsen (554_CR15) 2007; 448 554_CR19 SI Nikolaev (554_CR21) 2009; 4 15475110 - Trends Genet. 2004 Nov;20(11):529-33 19107649 - Crit Rev Clin Lab Sci. 2009;46(1):1-24 19684856 - PLoS One. 2009 Aug 17;4(8):e6659 18974389 - Clin Cancer Res. 2008 Nov 15;14(22):7237-45 18487283 - Clin Chem. 2008 Jul;54(7):1125-31 17512414 - Cell. 2007 May 18;129(4):823-37 14690610 - Mol Cell. 2003 Dec;12(6):1591-8 19181738 - Clin Chem. 2009 Apr;55(4):730-8 14690609 - Mol Cell. 2003 Dec;12(6):1577-89 15678104 - EMBO J. 2005 Feb 23;24(4):800-12 17158930 - Mol Cell Biol. 2007 Feb;27(4):1271-9 15765097 - Nat Genet. 2005 Apr;37(4):391-400 17603471 - Nature. 2007 Aug 2;448(7153):553-60 22593510 - Anticancer Res. 2012 May;32(5):2199-205 20226072 - Mob DNA. 2010 Jan 25;1(1):2 12142376 - Clin Chem. 2002 Aug;48(8):1212-7 17030614 - Mol Cell Biol. 2006 Dec;26(24):9185-95 19699193 - Clin Chim Acta. 2009 Nov;409(1-2):21-7 20196731 - Curr Mol Med. 2010 Mar;10(2):142-65 |
References_xml | – volume: 46 start-page: 1 year: 2009 end-page: 24 ident: CR2 article-title: Clinical use of circulating nucleosomes publication-title: Crit Rev Clin Lab Sci. doi: 10.1080/10408360802485875 – volume: 32 start-page: 2199 year: 2012 end-page: 2206 ident: CR11 article-title: Histone modifications H3K9me3 and H4K20me3 on circulating nucleosomes in cancer disease publication-title: Anticancer Res. – volume: 448 start-page: 553 year: 2007 end-page: 560 ident: CR15 article-title: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells publication-title: Nature doi: 10.1038/nature06008 – ident: CR19 – volume: 12 start-page: 1577 year: 2003 end-page: 1589 ident: CR7 article-title: Partitioning and plasticity of repressive histone methylation states in mammalian chromatin publication-title: Mol Cell. doi: 10.1016/S1097-2765(03)00477-5 – volume: 12 start-page: 1591 year: 2003 end-page: 1598 ident: CR8 article-title: Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains publication-title: Mol Cell. doi: 10.1016/S1097-2765(03)00479-9 – volume: 1 start-page: 2 year: 2010 ident: CR16 article-title: Epigenetic histone modifications of human transposable elements: genome defense versus exaptation publication-title: Mob DNA. doi: 10.1186/1759-8753-1-2 – start-page: 97 year: 2011 end-page: 103 ident: CR10 article-title: H3K9me3/H4K20me3 ratio in circulating nucleosomes as potential biomarker for colorectal cancer publication-title: Circulating nucleic acids in plasma and serum – volume: 27 start-page: 1271 year: 2007 end-page: 1279 ident: CR17 article-title: Distinctive signatures of histone methylation in transcribed coding and noncoding human beta-globin sequences publication-title: Mol Cell Biol. doi: 10.1128/MCB.01684-06 – volume: 129 start-page: 823 year: 2007 end-page: 837 ident: CR9 article-title: High-resolution profiling of histone methylations in the human genome publication-title: Cell. doi: 10.1016/j.cell.2007.05.009 – volume: 54 start-page: 1125 year: 2008 end-page: 1131 ident: CR4 article-title: Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma publication-title: Clin Chem. doi: 10.1373/clinchem.2007.101766 – volume: 14 start-page: 7237 year: 2008 end-page: 7245 ident: CR6 article-title: Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer publication-title: Clin Cancer Res. doi: 10.1158/1078-0432.CCR-08-0869 – volume: 24 start-page: 800 year: 2005 end-page: 812 ident: CR14 article-title: The profile of repeat-associated histone lysine methylation states in the mouse epigenome publication-title: EMBO J. doi: 10.1038/sj.emboj.7600545 – volume: 409 start-page: 21 year: 2009 end-page: 27 ident: CR12 article-title: Characterization of circulating DNA by parallel tagged sequencing on the 454 platform publication-title: Clin Chim Acta. doi: 10.1016/j.cca.2009.08.011 – volume: 10 start-page: 142 year: 2010 end-page: 165 ident: CR1 article-title: Circulating nucleic acids as a potential source for cancer biomarkers publication-title: Curr Mol Med. doi: 10.2174/156652410790963295 – volume: 20 start-page: 529 year: 2004 end-page: 533 ident: CR20 article-title: Analysis of the centromeric regions of the human genome assembly publication-title: Trends Genet. doi: 10.1016/j.tig.2004.08.008 – volume: 26 start-page: 9185 year: 2006 end-page: 9195 ident: CR18 article-title: Profile of histone lysine methylation across transcribed mammalian chromatin publication-title: Mol Cell Biol. doi: 10.1128/MCB.01529-06 – volume: 55 start-page: 730 year: 2009 end-page: 738 ident: CR13 article-title: Profile of the circulating DNA in apparently healthy individuals publication-title: Clin Chem. doi: 10.1373/clinchem.2008.113597 – volume: 4 start-page: e6659 year: 2009 ident: CR21 article-title: Detection of genomic variation by selection of a 9 mb DNA region and high throughput sequencing publication-title: PLoS One. doi: 10.1371/journal.pone.0006659 – volume: 48 start-page: 1212 year: 2002 end-page: 1217 ident: CR3 article-title: Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals publication-title: Clin Chem. – volume: 37 start-page: 391 year: 2005 end-page: 400 ident: CR5 article-title: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer publication-title: Nat Genet. doi: 10.1038/ng1531 – volume: 20 start-page: 529 year: 2004 ident: 554_CR20 publication-title: Trends Genet. doi: 10.1016/j.tig.2004.08.008 – volume: 24 start-page: 800 year: 2005 ident: 554_CR14 publication-title: EMBO J. doi: 10.1038/sj.emboj.7600545 – ident: 554_CR19 – volume: 26 start-page: 9185 year: 2006 ident: 554_CR18 publication-title: Mol Cell Biol. doi: 10.1128/MCB.01529-06 – volume: 14 start-page: 7237 year: 2008 ident: 554_CR6 publication-title: Clin Cancer Res. doi: 10.1158/1078-0432.CCR-08-0869 – volume: 12 start-page: 1591 year: 2003 ident: 554_CR8 publication-title: Mol Cell. doi: 10.1016/S1097-2765(03)00479-9 – volume: 48 start-page: 1212 year: 2002 ident: 554_CR3 publication-title: Clin Chem. doi: 10.1093/clinchem/48.8.1212 – volume: 409 start-page: 21 year: 2009 ident: 554_CR12 publication-title: Clin Chim Acta. doi: 10.1016/j.cca.2009.08.011 – volume: 1 start-page: 2 year: 2010 ident: 554_CR16 publication-title: Mob DNA. doi: 10.1186/1759-8753-1-2 – volume: 129 start-page: 823 year: 2007 ident: 554_CR9 publication-title: Cell. doi: 10.1016/j.cell.2007.05.009 – volume: 27 start-page: 1271 year: 2007 ident: 554_CR17 publication-title: Mol Cell Biol. doi: 10.1128/MCB.01684-06 – volume: 55 start-page: 730 year: 2009 ident: 554_CR13 publication-title: Clin Chem. doi: 10.1373/clinchem.2008.113597 – volume: 46 start-page: 1 year: 2009 ident: 554_CR2 publication-title: Crit Rev Clin Lab Sci. doi: 10.1080/10408360802485875 – volume: 10 start-page: 142 year: 2010 ident: 554_CR1 publication-title: Curr Mol Med. doi: 10.2174/156652410790963295 – volume: 32 start-page: 2199 year: 2012 ident: 554_CR11 publication-title: Anticancer Res. – volume: 37 start-page: 391 year: 2005 ident: 554_CR5 publication-title: Nat Genet. doi: 10.1038/ng1531 – start-page: 97 volume-title: Circulating nucleic acids in plasma and serum year: 2011 ident: 554_CR10 – volume: 4 start-page: e6659 year: 2009 ident: 554_CR21 publication-title: PLoS One. doi: 10.1371/journal.pone.0006659 – volume: 12 start-page: 1577 year: 2003 ident: 554_CR7 publication-title: Mol Cell. doi: 10.1016/S1097-2765(03)00477-5 – volume: 448 start-page: 553 year: 2007 ident: 554_CR15 publication-title: Nature doi: 10.1038/nature06008 – volume: 54 start-page: 1125 year: 2008 ident: 554_CR4 publication-title: Clin Chem. doi: 10.1373/clinchem.2007.101766 – reference: 15765097 - Nat Genet. 2005 Apr;37(4):391-400 – reference: 19699193 - Clin Chim Acta. 2009 Nov;409(1-2):21-7 – reference: 12142376 - Clin Chem. 2002 Aug;48(8):1212-7 – reference: 15678104 - EMBO J. 2005 Feb 23;24(4):800-12 – reference: 20226072 - Mob DNA. 2010 Jan 25;1(1):2 – reference: 17158930 - Mol Cell Biol. 2007 Feb;27(4):1271-9 – reference: 19181738 - Clin Chem. 2009 Apr;55(4):730-8 – reference: 14690610 - Mol Cell. 2003 Dec;12(6):1591-8 – reference: 18974389 - Clin Cancer Res. 2008 Nov 15;14(22):7237-45 – reference: 22593510 - Anticancer Res. 2012 May;32(5):2199-205 – reference: 17512414 - Cell. 2007 May 18;129(4):823-37 – reference: 18487283 - Clin Chem. 2008 Jul;54(7):1125-31 – reference: 15475110 - Trends Genet. 2004 Nov;20(11):529-33 – reference: 14690609 - Mol Cell. 2003 Dec;12(6):1577-89 – reference: 17030614 - Mol Cell Biol. 2006 Dec;26(24):9185-95 – reference: 20196731 - Curr Mol Med. 2010 Mar;10(2):142-65 – reference: 19684856 - PLoS One. 2009 Aug 17;4(8):e6659 – reference: 19107649 - Crit Rev Clin Lab Sci. 2009;46(1):1-24 – reference: 17603471 - Nature. 2007 Aug 2;448(7153):553-60 |
SSID | ssj0015996 |
Score | 2.2259529 |
Snippet | Modified histone tails in nucleosomes circulating in the blood bear the potential as cancer biomarkers. Recently, using chromatin immunopecipitation... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 329 |
SubjectTerms | Antibodies Biomarkers Biomarkers, Tumor - genetics Biomedical and Life Sciences Biomedicine Blood Cancer Research Chromatin Chromatin Immunoprecipitation Colorectal cancer Colorectal Neoplasms - blood Colorectal Neoplasms - genetics Deoxyribonucleic acid DNA DNA - blood DNA Methylation DNA sequencing Female Genomes High-Throughput Nucleotide Sequencing Histones Histones - blood Histones - genetics Histones - metabolism Humans Interspersed Repetitive Sequences Methylation Middle Aged Nucleosomes Nucleosomes - genetics Nucleotide sequence Plasma Plasma levels Polymerase chain reaction Proteins Repeated DNA sequences Research Article Tumors |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELZaKrVcUKG0LKXIlTiBrDp-JPGpQtuiVVE5FWlvkWM7FVJJln0cOPePd8brBBDqHqNMEiczmRn7G39DyElRaNFkuWe-NDlTkNCyEm1ZWV5b7jW3NrJ9XuWTa_VjqqdpwW2Ryip7nxgdte8crpF_yQR40TKTmfo6u2PYNQrR1dRC4yV5hdRlWNJVTIcJV4bUIxHtBF-DxGI9qhm3zkkELzkWJkBEZfppXHqWbD4DSmP8uXhLdlLiSM_Xmt4lL0K7R96M-35te-T1zwSTvyN_xwMN83qXJe0aOpGX5jZIRm3r6URdCo5HNqkneOpu5i4282p_0xZpjrtFdwuP_HZ1Tut7isTGLLX1ma2WNBVho_RNS5H8Gp0nyDs0pPk-ub74_ms8YanbAnOQtC1Z4WoXTBDSqqzILe5obaTjvNYmt9z40OjSgO_0VvnMlw4in7SN1EEH4UUw8j3Zars2HBCqNOYBHm4ShJK8NrUxAe6shDC5bviI8P5bVy5RkWNHjD_VA4kyqqcC9VSonkqPyOlwyWzNw7FJ-KhXYJV-yUX1YEAj8nk4DTpChMS2oVtFGVkgJU6xQUbClBdp-OA1PqyNYxgRzOdKRLJG5Ky3lkcD-N9wDzcP9yPZFrEHB9bQHJGt5XwVPkEmtKyPo7n_A7fPASY priority: 102 providerName: ProQuest |
Title | Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer |
URI | https://link.springer.com/article/10.1007/s13277-012-0554-5 https://www.ncbi.nlm.nih.gov/pubmed/23086575 https://www.proquest.com/docview/1271881314 https://www.proquest.com/docview/1273700507 https://www.proquest.com/docview/1315622460 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9sC-pL0art1Xqs4JMS2OxHkn08z6uHh4eIB-dT2OxupGCTch8PPvcf70wuSZVqwZeEkMlmk5ndmeW38xuAN2mqRRknPvKZSSKFAW2UkS0rywvLvebWNmyf82S6UJ-Wetnmca-73e4dJNnM1LfJbpLgRk5bCdAHRnoPDjQt3dGIF2LUQwfEN9JAnDjBEJtYB2X-rYk_ndGdCPMOOto4nfMncNhGi2y0U-9TeBCqI3g07oq0HcHDzy02_gyuxz338i61ktUlm8qZuQwyYrbybKpmgtOVbXUSPHMXK9dU8Kp-sIq4jet1fYmv_DAfseIXIzbjqK3lc7XdsHbnNUlfVIwYr2nGRHlH1rN6DovzybfxNGpLLEQOI7VNlLrCBROEtCpOE0tprKV0nBfaJJYbH0qdGZwwvVU-9plDdydtKXXQQXgRjHwB-1VdhRNgSpPz99hIEErywhTGBGxZCWESXfIB8O5f567lH6cyGD_zW-ZkUk-O6slJPbkewNv-kasd-cZ9wmedAvN2HK7zWKDvzWIZqwG87m-jjggWsVWot42MTIkHJ71HRuI6l7j38DOOd8bR9wgXcRnBVwN411nLbx34V3dP_0v6JTwWTR0O2kdzBvub1Ta8wmhoUwxhL12meMzG8RAORh-_zyZ4fj-Zf_k6bEbGDbfhApM |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqUS5ICivQIFFggvIYr0PPw4IlbRVStoIoVbqzax316gStUMeQj3zf_iNzPhVUEVuPVqerDeZz7Mz-Xa_AXgVx1oUYeQCl6RRoDChDRLCsjI8N9xpbkyt9jmNxqfq05k-24Df3VkY2lbZxcQ6ULvK0n_k70KBUTQJZag-zH4E1DWK2NWuhUYDi4m__Ikl2-L94R7697UQB_sno3HQdhUILCYnyyC2ufWpF9KoMI4MndwspOU812lkeOp8oRMsxCNnlAtdYjHCS1NI7bUXTngSX8KQv6kkljID2Py4P_38pectSOyk5lcxupGUWcej1of1JNGlnLZC4Boe6H9Xwmvp7TVqtl7xDu7CnTZVZbsNtu7Bhi-3YWvUdYjbhlvHLTF_H36NeuHn5lwnqwo2lpP0wsuAmdKxsZoITlemBYR3zJ7Pbd0-rPzGShJWrhbVBT5yb7rL8ktGUspB20hotlqydts3WZ-XjOS2KVyjvSXozh_A6Y144iEMyqr0j4EpTZmHw0G8UJLnaZ6mHkdWQqSRLvgQePdbZ7YVP6ceHN-zK9lmck-G7snIPZkewpv-I7NG-WOd8U7nwKwNAovsCrJDeNnfRh8RJ2NKX61qGxmTCE-8xkZikU3Cf_g1HjXg6GeEFWRC3NkQ3nZo-WsC_5vuk_XTfQFb45Pjo-zocDp5CrdF3QGEdvDswGA5X_lnmIct8-ct-Bl8ven37Q-IRz-d |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIULgvJaKGAkTiCrjh9JfFxtWS0srDiwUm-RYztVJeqsdrMHzvxxZvIqqFCJY5SJ42TGnrG-mW8IeZtlWlRJ6pnPTcoUBLQsR1tWlpeWe82tbdk-V-lirT6d6bO-z-luyHYfIMmupgFZmmJzsvHVyVXhm0TokWNaAfhDpm-TO7AbJ2jWazEdYQTkHmnhTthskFlsgDX_NsSfjulatHkNKW0d0PwBud9HjnTaqfohuRXiEbk7Gxq2HZHDLz1O_oj8nI08zF2ZJa0rupBLcxkkozZ6ulBLwfHK9voJnrqLrWu7ecVzGpHnuN7Vl_DK09WUlj8oMhuzvq_PZt_QPgsbpS8iRfZr3D1B3qElbR-T9fzDt9mC9e0WmIOorWGZK10wQUirkiy1WNJaScd5qU1qufGh0rmBzdNb5ROfO3B90lZSBx2EF8HIJ-Qg1jE8I1RpDAQ8DBKEkrw0pTEBRlZCmFRXfEL48K8L13ORY0uM78UVizKqpwD1FKieQk_Iu_GRTUfEcZPw8aDAol-TuyIR4IdzsBI1IW_G26AjhEhsDPW-lZEZcuJkN8hIOPMiDx98xtPOOMYZwYEuRyhrQt4P1vLbBP413ef_Jf2aHH49nRefP66WL8g90bbnwPSaY3LQbPfhJQRJTfmqXQi_AKHvBOA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+H3K9me3-+and+H4K20me3-associated+circulating+nucleosomal+DNA+by+high-throughput+sequencing+in+colorectal+cancer&rft.jtitle=Tumor+biology&rft.au=Gezer%2C+Ugur&rft.au=Ustek%2C+Duran&rft.au=Y%C3%B6r%C3%BCker%2C+Ebru+E&rft.au=Cakiris%2C+Aris&rft.date=2013-02-01&rft.eissn=1423-0380&rft.volume=34&rft.issue=1&rft.spage=329&rft_id=info:doi/10.1007%2Fs13277-012-0554-5&rft_id=info%3Apmid%2F23086575&rft.externalDocID=23086575 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1010-4283&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1010-4283&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1010-4283&client=summon |